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Varsani et al, 2013: SUPPLEMENTARY DATA   
 
Supplementary Table S1A: The JDM Biopsy Score tool as used  
 
JDM BIOPSY SCORE TOOL  
Refer to detailed instructions below for definitions 
 
  
Case identifier   Date scored   
Date of Biopsy   Gender (M/F)   
Research code   Age at biopsy   
   
  
DOMAIN 
Score 
options 
SCORE HERE NOTES 
INFLAMMATORY DOMAIN       
CD3+  endomysial infiltration 0, 1, 2     
CD3+  perimysial infiltration 0, 1, 2     
CD3+  perivascular infiltration 0, 1, 2     
CD68+ endomysial infiltration  0, 1, 2     
CD68+ perimysial infiltration 0, 1, 2     
CD68+ perivascular infiltration 0, 1, 2     
VASCULAR DOMAIN       
Capillary dropout  0 (N) or 1 (Y)     
Arterial abnormality 0 (N) or 1 (Y)     
Infarction 0 (N) or 1 (Y)     
MUSCLE FIBRE DOMAIN       
MHC Class I over- expression 0 (N) or 1 (Y)     
Perifascicular atrophy  0, 1, 2     
Neonatal myosin 0 or 1     
Fibre atrophy: non perifascicular  0 (N) or 1 (Y)     
Regeneration/ Degeneration /Necrosis: peri-
fascicular 
0, 1, 2     
Regeneration/ Degeneration /Necrosis: non-
peri-fascicular 
0, 1, 2     
Internal myonuclei in non-basophilic otherwise 
normal fibres 
0 or 1     
CONNECTIVE TISSUE DOMAIN       
Any endomysial fibrosis 0 (N) or 1 (Y)     
Any perimysial fibrosis 0 (N) or 1 (Y)     
 
VISUAL ANALOGUE SCALE - OVERALL IMPRESSION OF ABNORMALITY 
 0  10  
  
     no abnormality              much abnormality 
Please make a mark on this 10cm line to indicate overall severity from no abnormality to much abnormality; do 
not write a number. 
 
Supplementary Table S1B Score tool definitions and Instructions  
 
JDM SEVERITY SCORE TOOL: INSTRUCTIONS for USE 
 
DOMAIN 
Score 
options 
Definitions and Instructions 
CD3+ endomysial infiltration 
 
0, 1, 2 For each of endomysial, perimysial, perivascular 
distributions, score for CD3+ infiltrating cells as 
follows:  if none, or less than 4 cells in x20 field - 
score 0;  if >4 cells in a x20 field and/or 1 cluster 
(where a cluster is approx 10 cells or more) - score 
1;  if >2 clusters in whole biopsy, and/or diffusely 
infiltrating cells (ie >20 cells in a 20x field) - score 2 
CD3+ perimysial infiltration 
 
0, 1, 2 
CD3+ perivascular infiltration 
 
0, 1, 2 
CD68+ endomysial infiltration 
 
0, 1, 2 For each of endomysial, perimysial, perivascular 
distributions, score for CD68+ infiltrating cells as 
follows: if none, or less than 4 cells in x20 field - 
score 0; if >4 cells in a x20 field and/or 1 cluster 
(where a cluster is approx 10 cells or more) - score 
1;  if >2 clusters in whole biopsy, and/or diffusely 
infiltrating cells (ie >20 cells in a 20x field) - score 2 
CD68+ perimysial infiltration 
 
0, 1, 2 
CD68+ perivascular infiltration 
 
0, 1, 2 
VASCULAR DOMAIN   
Capillary dropout  
(Using immunohistochemistry 
for CD31) 
0 (N) or 1 (Y) Obvious and marked decrease in the density of 
capillary network, not restricted to areas of 
perifascicular atrophy. Absence ! N; Presence ! Y 
Arterial abnormality 
 
0 (N) or 1 (Y) Mural thickening and/or endothelial swelling and/or 
transmural inflammation in arteries/arterioles. 
Absence ! N; Presence ! Y 
Infarction 
 
0 (N) or 1 (Y) Well demarcated regional loss of muscle fibre 
nuclei and loss of normal cytoarchitecture. 
Absence ! N; Presence ! Y 
MUSCLE FIBRE DOMAIN   
MHC Class I over- expression 
 
0 (N) or 1 (Y) Presence of MHC class I staining on or in muscle 
fibres. Absence ! N; Presence ! Y 
Perifascicular atrophy  
 
0, 1, 2 Affecting > 6 fibres out of 10 along one edge of a 
fasciculus, not exclusive to type IIb fibres. Absent - 
score 0. Present in one or 2 fascicles - score 1. 
Present in 3 or more fascicles - score 2 
Neonatal myosin 
(using immunohistochemistry 
for neonatal myosin)  
0 or 1 Less than 6 positive fibres in a x20 field - score 0; 
> 6 positive fibres in a x20 field - score 1 
Fibre atrophy: non-
perifascicular 
0 (N) or 1 (Y) Fibre atrophy: non-perifascicular (outside normal 
variation for age). Absence ! N; Presence ! Y 
Regeneration/ Degeneration 
/Necrosis:  
peri-fascicular 
0, 1, 2 Includes: focal basophilia within a fibre, 
vacuolation, myofibrillar rarefaction and/or pallor, 
myophagocytosis, acid phosphatase positive 
fibres.  For each of perifasciular and non-
perifascicular, score as follows. None ! score 0. If 
any of the features in 1 or 2 fasciculi score 1. If any 
of the features in 3 or more fasciculi score 2 
Regeneration/ Degeneration 
/Necrosis:  
non-peri-fascicular 
0, 1, 2 
Internal myonuclei in non-
basophilic otherwise normal 
fibres 
0 or 1 Internal myonuclei in non-basophilic cells (in 
otherwise normal fibres) in 1 or more fasciculi 
excluding myotendinous junctions. If < 3% fibres - 
score 0. If > 3% fibres - score 1 
CONNECTIVE TISSUE DOMAIN  
Any endomysial fibrosis 0 (N) or 1 (Y) For fibrosis in each of endomysial and perimysial 
distributions, score as follows: Absence: score N.  
Presence of any: score Y 
Any perimysial fibrosis 
  
0 (N) or 1 (Y) 
 
Supplementary Table S2: Intra-rater agreement for items of the  
score tool assessed by proportion of agreement (pA).  
 
 
 
Proportion of 
Agreement 
Median* (range) 
Item name  
CD3+ endomysial infiltration 0.8 (0.5 ! 1.0) 
CD3+ perimysial  infiltration 0.7 (0.6 ! 0.9) 
CD3+ perivascular infiltration 0.8 (0.6 ! 1.0) 
CD68+ endomysial infiltration 0.8 (0.6 ! 1.0) 
CD68+ perimysial infiltration 0.8 (0.6 ! 0.9) 
CD68+ perivascular infiltration 0.6 (0.5 ! 0.8) 
Capillary dropout 0.8 (0.5 ! 1.0) 
Arterial abnormality 0.9 (0.5 ! 0.9) 
Perifascicular atrophy 0.8 (0.6 - 1.0) 
Neonatal myosin 1.0 (0.8 ! 1.0) 
Fibre atropy ! no-perifascicular 0.8 (0.5 ! 1.0) 
Regeneration/degeneration/necrosis: 
peri-fascicular 
0.8 (0.5 ! 1.0) 
Regeneration/degeneration/necrosis: 
non peri-fascicular 
0.8 (0.4 ! 0.9) 
Internal myonuclei 0.9 (0.9 ! 1.0) 
Endomysial fibrosis 0.9 (0.6 ! 1.0) 
Perimysial fibrosis 0.8 (0.6 ! 1.0) 
 
*median evaluated over 8 scorers. Bold indicates informative items,  
defined as those which achieved good or good* in original scoring exercise [4]  
and in both of the 11x11 scoring exercises conducted for this study 
 
 
Supplementary Table S3 Correlations between tool items and measures of disease 
activity Physicians global assessment and childhood myositis assessment score 
 
 
 PGA CMAS 
Domain & Item    r p-value r p-value 
INFLAMMATORY DOMAIN 
    
CD3+  endomysial 
infiltration* 
n/a 0.02 n/a 0.16 
CD3+ perimysial infiltration* n/a 0.02 n/a 0.13 
CD68+ endomysial 
infiltration* 
n/a 0.01 n/a 0.05 
Inflammatory Domain 
total**(modified) 
          
0.61 0.001 -0.43 0.03 
 
MUSCLE FIBRE DOMAIN 
    
Perifascicular atrophy*  n/a 0.23 n/a 0.15 
Neonatal myosin* n/a 0.01 n/a 0.02 
Regeneration/ Degeneration 
/Necrosis: peri-fascicular* 
n/a 0.03 n/a 0.18 
Muscle Fibre Domain 
total**(modified) 
0.40 0.01 -0.41 0.04 
     
* p-value - Kruskall Wallis test, ** p-value - test of independence: r ! "#$%&'%()*+&%(,+
correlation coefficient.  
n/a ! r value not available, since the Kruskall Wallis test does not generate a r value 
